How much does Ribociclib cost in medical insurance?

Ribociclib (Ribociclib) is a selective cyclin-dependent kinase4/6 (CDK4/6) inhibitor for the treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced or metastatic breast cancer. The drug was developed by the Swiss company Novartis and sold under the trade name Kisqali. Riboxiclib prevents the progression of the G1 phase of the cell cycle by inhibiting CDK4 and CDK6, thereby preventing the proliferation of cancer cells.

Ribociclib has been launched in the country and has been included in the medical insurance catalog. This means that patients can reimburse part of their drug costs through medical insurance, which greatly reduces their financial burden. At present, the price of ribociclib in China is about more than 8,000 yuan. Specific prices and medical insurance reimbursement ratios vary by region and hospital. It is recommended that patients consult the local hospital pharmacy before purchasing to obtain the latest and most accurate price information.

In addition, there are relatively cheaper Indian versions of original drugs on domestic and foreign markets. The price of the Indian version of Ribociclib (Rebociclib) is about 3,000 yuan. Although the price is lower, its efficacy and ingredients are consistent with those of domestic original drugs. Indian pharmaceutical companies are known for producing high-quality generic drugs, and their strict production standards and quality control ensure the safety and effectiveness of the drugs. Therefore, the Indian version of the original drug provides a more economical option for patients who require long-term use of ribociclib.

The introduction and medical insurance coverage of ribociclib has provided new treatment hope for many breast cancer patients. Clinical studies of Ribociclib have shown that it can significantly extend the progression-free survival (PFS) of patients and improve their quality of life. Common side effects include neutropenia, elevated liver enzymes, nausea, fatigue, and alopecia. During treatment, patients need to regularly monitor blood routine, liver function and electrocardiogram to ensure safe medication.